Health Catalyst, Inc. (HCAT)

Health Catalyst Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	296.79	295.94	276.24	241.93	188.85	154.94
Revenue Growth (YoY)	5.24%	7.13%	14.18%	28.11%	21.88%	37.63%
Cost of Revenue	164.32	164.11	143.05	124.35	98.08	75.35
Gross Profit	132.48	131.83	133.19	117.57	90.77	79.6
Selling, General & Admin	135.1	143.88	149.22	160.96	114.65	79
Research & Development	70.42	72.63	75.68	62.73	53.52	46.25
Other Operating Expenses	41.75	42.22	48.3	37.53	18.73	9.21
Operating Expenses	247.27	258.73	273.19	261.22	186.89	134.46
Operating Income	-114.8	-126.9	-140.01	-143.65	-96.13	-54.87
Interest Expense / Income	-7.31	-9.11	1.68	16.46	11.57	3.42
Other Expense / Income	-2.34	-	-	-	8.51	1.67
Pretax Income	-105.14	-117.79	-141.68	-160.11	-116.21	-59.95
Income Tax	0.4	0.36	-4.28	-6.9	-1.19	0.14
Net Income	-105.54	-118.15	-137.4	-153.21	-115.02	-60.1
Preferred Dividends	0	0	0	0	0	180.83
Net Income Common	-105.54	-118.15	-137.4	-153.21	-115.02	-240.92
Shares Outstanding (Basic)	59	56	54	47	40	19
Shares Outstanding (Diluted)	59	56	54	47	40	19
Shares Change	5.60%	4.32%	13.86%	20.12%	110.99%	290.60%
EPS (Basic)	-1.84	-2.09	-2.56	-3.23	-2.91	-12.86
EPS (Diluted)	-1.84	-2.09	-2.63	-3.23	-2.91	-12.86
Free Cash Flow	-29.85	-46.24	-50.4	-40.2	-35.35	-34.52
Free Cash Flow Per Share	-0.51	-0.82	-0.94	-0.85	-0.89	-1.84
Gross Margin	44.64%	44.55%	48.21%	48.60%	48.06%	51.37%
Operating Margin	-38.68%	-42.88%	-50.68%	-59.38%	-50.90%	-35.41%
Profit Margin	-35.56%	-39.92%	-49.74%	-63.33%	-60.91%	-155.49%
Free Cash Flow Margin	-10.06%	-15.63%	-18.24%	-16.61%	-18.72%	-22.28%
EBITDA	-67.7	-81.68	-88.48	-102.54	-81.61	-43.86
EBITDA Margin	-22.81%	-27.60%	-32.03%	-42.38%	-43.22%	-28.31%
Depreciation & Amortization	44.76	45.21	51.53	41.11	23.03	12.67
EBIT	-112.46	-126.9	-140.01	-143.65	-104.64	-56.54
EBIT Margin	-37.89%	-42.88%	-50.68%	-59.38%	-55.41%	-36.49%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).